关注
Davide Moi
标题
引用次数
引用次数
年份
Indole derivatives as multifunctional drugs: Synthesis and evaluation of antioxidant, photoprotective and antiproliferative activity of indole hydrazones
M Demurtas, A Baldisserotto, I Lampronti, D Moi, G Balboni, S Pacifico, ...
Bioorganic chemistry 85, 568-576, 2019
992019
Selective inhibition of histone deacetylase 10: hydrogen bonding to the gatekeeper residue is implicated
M Géraldy, M Morgen, P Sehr, RR Steimbach, D Moi, J Ridinger, I Oehme, ...
Journal of medicinal Chemistry 62 (9), 4426-4443, 2019
792019
Hydroxamic acid derivatives: From synthetic strategies to medicinal chemistry applications
A Citarella, D Moi, L Pinzi, D Bonanni, G Rastelli
ACS omega 6 (34), 21843-21849, 2021
532021
Benzofuran hydrazones as potential scaffold in the development of multifunctional drugs: Synthesis and evaluation of antioxidant, photoprotective and antiproliferative activity
A Baldisserotto, M Demurtas, I Lampronti, D Moi, G Balboni, S Vertuani, ...
European journal of medicinal chemistry 156, 118-125, 2018
522018
Synthesis and evaluation of antioxidant and antiproliferative activity of 2-arylbenzimidazoles
A Baldisserotto, M Demurtas, I Lampronti, M Tacchini, D Moi, G Balboni, ...
Bioorganic Chemistry 94, 103396, 2020
352020
Synthesis and biological evaluation of novel pyrazoline-based aromatic sulfamates with potent carbonic anhydrase isoforms II, IV and IX inhibitory efficacy
A Nocentini, D Moi, G Balboni, S Salvadori, V Onnis, CT Supuran
Bioorganic Chemistry 77, 633-639, 2018
342018
Discovery of thiazolin-4-one-based aromatic sulfamates as a new class of carbonic anhydrase isoforms I, II, IV, and IX inhibitors
A Nocentini, D Moi, G Balboni, V Onnis, CT Supuran
Bioorganic Chemistry 77, 293-299, 2018
282018
Structure-activity relationship with pyrazoline-based aromatic sulfamates as carbonic anhydrase isoforms I, II, IX and XII inhibitors: Synthesis and biological evaluation
D Moi, A Nocentini, A Deplano, G Balboni, CT Supuran, V Onnis
European Journal of Medicinal Chemistry 182, 111638, 2019
262019
Appliance of the piperidinyl-hydrazidoureido linker to benzenesulfonamide compounds: Synthesis, in vitro and in silico evaluation of potent carbonic anhydrase II, IX and XII …
D Moi, A Nocentini, A Deplano, SM Osman, ZA AlOthman, V Piras, ...
Bioorganic chemistry 98, 103728, 2020
172020
Sulfonamide/sulfamate switch with a series of piperazinylureido derivatives: Synthesis, kinetic and in silico evaluation as carbonic anhydrase isoforms I, II, IV, and IX inhibitors
A Nocentini, D Moi, A Deplano, SM Osman, ZA AlOthman, G Balboni, ...
European Journal of Medicinal Chemistry 186, 111896, 2020
162020
Synthesis and in vitro evaluation of piperazinyl-ureido sulfamates as steroid sulfatase inhibitors
D Moi, PA Foster, LG Rimmer, A Jaffri, A Deplano, G Balboni, V Onnis, ...
European Journal of Medicinal Chemistry 182, 111614, 2019
132019
Recent advances in SARS-CoV-2 main protease inhibitors: from nirmatrelvir to future perspectives
A Citarella, A Dimasi, D Moi, D Passarella, A Scala, A Piperno, N Micale
Biomolecules 13 (9), 1339, 2023
122023
Synthesis of SARS-CoV-2 M pro inhibitors bearing a cinnamic ester warhead with in vitro activity against human coronaviruses
A Citarella, D Moi, M Pedrini, H Pérez-Peña, S Pieraccini, A Dimasi, ...
Organic & Biomolecular Chemistry 21 (18), 3811-3824, 2023
122023
In-vitro evaluation of antioxidant, antiproliferative and photo-protective activities of benzimidazolehydrazone derivatives
A Baldisserotto, M Demurtas, I Lampronti, M Tacchini, D Moi, G Balboni, ...
Pharmaceuticals 13 (4), 68, 2020
122020
Dual targeting strategies on histone deacetylase 6 (HDAC6) and heat shock protein 90 (Hsp90)
D Bonanni, A Citarella, D Moi, L Pinzi, E Bergamini, G Rastelli
Current Medicinal Chemistry 29 (9), 1474-1502, 2022
112022
Synthesis of potent and selective HDAC6 inhibitors led to unexpected opening of a quinazoline ring
D Moi, A Citarella, D Bonanni, L Pinzi, D Passarella, A Silvani, C Giannini, ...
RSC advances 12 (18), 11548-11556, 2022
82022
Investigation on hydrazonobenzenesulfonamides as human carbonic anhydrase I, II, IX and XII inhibitors
D Moi, S Vittorio, A Angeli, G Balboni, CT Supuran, V Onnis
Molecules 28 (1), 91, 2022
72022
Discovery of a Novel Trifluoromethyl Diazirine Inhibitor of SARS-CoV-2 Mpro
A Citarella, D Moi, M Pedrini, H Pérez-Peña, S Pieraccini, C Stagno, ...
Molecules 28 (2), 514, 2023
52023
Inhibitors of histone deacetylase 6 based on a novel 3-hydroxy-isoxazole zinc binding group
P Linciano, L Pinzi, S Belluti, U Chianese, R Benedetti, D Moi, L Altucci, ...
Journal of enzyme inhibition and medicinal chemistry 36 (1), 2080-2086, 2021
52021
Discovery of potent pyrrolo-pyrimidine and purine HDAC inhibitors for the treatment of advanced prostate cancer
D Moi, D Bonanni, S Belluti, P Linciano, A Citarella, S Franchini, C Sorbi, ...
European Journal of Medicinal Chemistry 260, 115730, 2023
42023
系统目前无法执行此操作,请稍后再试。
文章 1–20